Home Vital Sentences Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

The Word Brain 2015Free PDF | Print
A short guide to fast language learning

Free Abstracts

  Malignant Melanoma

  Free Subscription


16.03.2015

1 Am J Dermatopathol
2 Ann Surg Oncol
2 Anticancer Res
1 Br J Dermatol
2 Cancer Res
1 Int J Cancer
2 J Am Acad Dermatol
1 J Immunol
2 J Invest Dermatol
6 Melanoma Res
1 Nat Med
1 Oncogene
4 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Dermatopathol

  1. PASTUSHENKO I, Vicente-Arregui S, Van den Eynden GG, Gracia-Cazana T, et al
    Melanomas Arising on Skin With Chronic Sun-Induced Damage Exhibit Low Degree of Angiogenesis and Lymphangiogenesis.
    Am J Dermatopathol. 2015.
    PubMed     Text format     Abstract available


    Ann Surg Oncol

  2. MAKER AV, Iteld L
    Closure of Melanoma Defects on the Sole of the Foot Using Glaborous Skin: The End of the Flap?
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available

  3. KANDA M, Nomoto S, Oya H, Takami H, et al
    The Expression of Melanoma-Associated Antigen D2 Both in Surgically Resected and Serum Samples Serves as Clinically Relevant Biomarker of Gastric Cancer Progression.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


    Anticancer Res

  4. DRUEPPEL D, Schultheis B, Solass W, Ergonenc H, et al
    Primary malignant melanoma of the breast: case report and review of the literature.
    Anticancer Res. 2015;35:1709-13.
    PubMed     Text format     Abstract available

  5. JAVAID S, Terai K, Dudek AZ
    Chondroitin Sulfate Proteoglycan-4 Does Not Protect Melanoma Cells During Inhibition of PI3K and mTOR Pathways.
    Anticancer Res. 2015;35:1279-84.
    PubMed     Text format     Abstract available


    Br J Dermatol

  6. MAR VJ, Liu W, Devitt B, Wong SQ, et al
    The role of BRAF mutations in primary melanoma growth rate and survival.
    Br J Dermatol. 2015 Mar 5. doi: 10.1111/bjd.13756.
    PubMed     Text format     Abstract available


    Cancer Res

  7. ULLRICH N, Heinemann A, Nilewski E, Scheffrahn I, et al
    CEACAM1-3S drives melanoma cells into NK cell-mediated cytolysis and enhances patient survival.
    Cancer Res. 2015 Mar 5. pii: canres.1752.2014.
    PubMed     Text format     Abstract available

  8. DUDEK-PERIC AM, Ferreira GB, Muchowicz A, Wouters J, et al
    Anti-tumor immunity triggered by melphalan is potentiated by melanoma cell surface associated calreticulin.
    Cancer Res. 2015 Mar 11. pii: canres.2089.2014.
    PubMed     Text format     Abstract available


    Int J Cancer

  9. JOSHI S, Wels C, Beham-Schmid C, Fukunaga-Kalabis M, et al
    Galpha(13) mediates human cytomegalovirus-encoded chemokine receptor US28 induced cell death in melanoma.
    Int J Cancer. 2015 Mar 6. doi: 10.1002/ijc.29506.
    PubMed     Text format     Abstract available


    J Am Acad Dermatol

  10. FRYDENLUND N, Leone DA, Mitchell B, Yang S, et al
    Neurotrophin receptors and perineural invasion in desmoplastic melanoma.
    J Am Acad Dermatol. 2015 Mar 7. pii: S0190-9622(15)00091.
    PubMed     Text format     Abstract available

  11. GERAMI P, Cook RW, Russell MC, Wilkinson J, et al
    Gene expression profiling for molecular staging of cutaneous melanoma in patients undergoing sentinel lymph node biopsy.
    J Am Acad Dermatol. 2015 Mar 3. pii: S0190-9622(15)00040.
    PubMed     Text format     Abstract available


    J Immunol

  12. GILLGRASS A, Gill N, Babian A, Ashkar AA, et al
    The absence or overexpression of IL-15 drastically alters breast cancer metastasis via effects on NK cells, CD4 T cells, and macrophages.
    J Immunol. 2014;193:6184-91.
    PubMed     Text format     Abstract available


    J Invest Dermatol

  13. SHAO Y, Le K, Cheng H, Aplin AE, et al
    NFkappaB-Regulation of c-FLIP Promotes TNFalpha-Mediated RAF Inhibitor Resistance in Melanoma.
    J Invest Dermatol. 2015 Mar 9. doi: 10.1038/jid.2015.
    PubMed     Text format     Abstract available

  14. YAZAWA EM, Geddes-Sweeney JE, Cedeno-Laurent F, Walley KC, et al
    Melanoma Cell Galectin-1 Ligands Functionally Correlate with Malignant Potential.
    J Invest Dermatol. 2015 Mar 10. doi: 10.1038/jid.2015.
    PubMed     Text format     Abstract available


    Melanoma Res

  15. JANGARD M, Zebary A, Ragnarsson-Olding B, Hansson J, et al
    TERT promoter mutations in sinonasal malignant melanoma: a study of 49 cases.
    Melanoma Res. 2015.
    PubMed     Text format     Abstract available

  16. SEELEY AR, De Los Santos JF, Conry RM
    Induction vemurafenib followed by consolidative radiation therapy for surgically incurable melanoma.
    Melanoma Res. 2015.
    PubMed     Text format     Abstract available

  17. VAN DEN HURK K, Balint B, Toomey S, O'Leary PC, et al
    High-throughput oncogene mutation profiling shows demographic differences in BRAF mutation rates among melanoma patients.
    Melanoma Res. 2015.
    PubMed     Text format     Abstract available

  18. FERRUCCI PF, Minchella I, Mosconi M, Gandini S, et al
    Dacarbazine in combination with bevacizumab for the treatment of unresectable/metastatic melanoma: a phase II study.
    Melanoma Res. 2015.
    PubMed     Text format     Abstract available

  19. VAN ENGEN-VAN GRUNSVEN AC, Baar MP, Pfundt R, Rijntjes J, et al
    Whole-genome copy-number analysis identifies new leads for chromosomal aberrations involved in the oncogenesis and metastastic behavior of uveal melanomas.
    Melanoma Res. 2015.
    PubMed     Text format     Abstract available

  20. CHOROMANSKA A, Kulbacka J, Rembialkowska N, Pilat J, et al
    Effects of electrophotodynamic therapy in vitro on human melanoma cells - melanotic (MeWo) and amelanotic (C32).
    Melanoma Res. 2015.
    PubMed     Text format     Abstract available


    Nat Med

  21. OVERWIJK WW
    Human CD4(+) T cells spontaneously detect somatic mutations in cancer cells.
    Nat Med. 2015;21:12-4.
    PubMed     Text format    


    Oncogene

  22. YANG Y, Gorzelanny C, Bauer AT, Halter N, et al
    Nuclear heparanase-1 activity suppresses melanoma progression via its DNA-binding affinity.
    Oncogene. 2015 Mar 9. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    PLoS One

  23. VERSLUIS M, de Lange MJ, van Pelt SI, Ruivenkamp CA, et al
    Digital PCR Validates 8q Dosage as Prognostic Tool in Uveal Melanoma.
    PLoS One. 2015;10:e0116371.
    PubMed     Text format     Abstract available

  24. ZIMMER L, Vaubel J, Mohr P, Hauschild A, et al
    Phase II DeCOG-Study of Ipilimumab in Pretreated and Treatment-Naive Patients with Metastatic Uveal Melanoma.
    PLoS One. 2015;10:e0118564.
    PubMed     Text format     Abstract available

  25. BRONCHALO-VICENTE L, Rodriguez-Del Rio E, Freire J, Calderon-Gonzalez R, et al
    A Novel Therapy for Melanoma Developed in Mice: Transformation of Melanoma into Dendritic Cells with Listeria monocytogenes.
    PLoS One. 2015;10:e0117923.
    PubMed     Text format     Abstract available

  26. PFARR K, Danciu C, Arlt O, Neske C, et al
    Simultaneous and dose dependent melanoma cytotoxic and immune stimulatory activity of betulin.
    PLoS One. 2015;10:e0118802.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


All AMEDEO services are free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Amedeo is a Flying Publisher website.

   Design: